Plasmodium coatneyi in rhesus macaques replicates the multisystemic dysfunction of severe malaria in humans

Infection and Immunity

Volumn 81, Issue 6, 2013, Pages 1889-1904

  Moreno, Alberto ^a,b   Cabrera Mora, Monica ^a   Garcia, AnaPatricia ^a,c   Orkin, Jack ^a   Strobert, Elizabeth ^a   Barnwell, John W ^d   Galinskia, Mary R ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; CARBON TETRACHLORIDE; ERYTHROCYTE MEMBRANE PROTEIN 1; ERYTHROPOIETIN; HEMOGLOBIN; HEMOZOIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOTINYLATION; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; DYSERYTHROPOIESIS; ERYTHROCYTE; FLUID THERAPY; HEMOGLOBIN BLOOD LEVEL; HYPERTRIGLYCERIDEMIA; HYPOALBUMINEMIA; IMMUNE RESPONSE; IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KIDNEY DYSFUNCTION; MALARIA; MALE; METABOLIC DISORDER; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PARASITEMIA; PLASMODIUM; PLASMODIUM COATNEYI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RETICULOCYTE COUNT; SINGLE DRUG DOSE; THROMBOCYTOPENIA; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL;

ANEMIA; ANIMALS; BLOOD COAGULATION; BONE MARROW DISEASES; DISEASE MODELS, ANIMAL; ERYTHROPOIESIS; ERYTHROPOIETIN; MACACA MULATTA; MALARIA; MALE; MONKEY DISEASES; PLASMODIUM; RANDOM ALLOCATION; TIME FACTORS;

EID: 84877829193     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00027-13     Document Type: Article

References (131)

1. WHO. 2011. World malaria report 2011. World Health Organization, Geneva, Switzerland.
2. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214-217.
3. Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, Alpers MP, Muller I. 2008. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 5:e127. doi:10.1371/journal.pmed.0050127.
4. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN. 2008. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 5:e128. doi:10.1371/journal.pmed.0050128.
5. WHO. 2000. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl 1):1-90.
6. Lanca EF, Magalhaes BM, Vitor-Silva S, Siqueira AM, Benzecry SG, Alexandre MA, O'Brien C, Bassat Q, Lacerda MV. 2012. Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon. PLoS One 7:e35406. doi:10.1371/journal.pone.0035406.
7. White NJ, Turner GD, Medana IM, Dondorp AM, Day NP. 2010. The murine cerebral malaria phenomenon. Trends Parasitol. 26:11-15.
8. Craig AG, Grau GE, Janse C, Kazura JW, Milner D, Barnwell JW, Turner G, Langhorne J, on behalf of the participants of the Hinxton Retreat meeting on Animal Models for Research on Severe Malaria. 2012. The role of animal models for research on severe malaria. PLoS Pathog. 8:e1002401. doi:10.1371/journal.ppat.1002401.
9. Galinski MR, Barnwell JW. 2012. Nonhuman primate models for human malaria research, p 299-323. In Christian R, Abee KM, Tardif S, Morris T (ed), Nonhuman primates in biomedical research, 2nd ed. Academic Press, London, United Kingdom.
10. Langhorne J, Buffet P, Galinski M, Good M, Harty J, Leroy D, Mota M, Pasini E, Renia L, Riley E, Stins M, Duffy P. 2011. The relevance of non-human primate and rodent malaria models for humans. Malaria J. 10:23. doi:10.1186/1475-2875-10-23.
11. Desowitz RS, Miller LH, Buchanan RD, Permpanich B. 1969. The sites of deep vascular schizogony in Plasmodium coatneyi malaria. Trans. R. Soc. Trop. Med. Hyg. 63:198-202.
12. Desowitz RS, Miller LH, Buchanan RD, Yuthasastrkosol V, Permpanich B. 1967. Comparative studies on the pathology and host physiology of malarias. I. Plasmodium coatneyi. Ann. Trop. Med. Parasitol. 61:365-374.
13. Smith CD, Brown AE, Nakazawa S, Fujioka H, Aikawa M. 1996. Multi-organ erythrocyte sequestration and ligand expression in rhesus monkeys infected with Plasmodium coatneyi malaria. Am. J. Trop. Med. Hyg. 55:379-383.
14. Aikawa M, Brown A, Smith CD, Tegoshi T, Howard RJ, Hasler TH, Ito Y, Perry G, Collins WE, Webster K. 1992. A primate model for human cerebral malaria: Plasmodium coatneyi-infected rhesus monkeys. Am. J. Trop. Med. Hyg. 46:391-397.
15. Udomsangpetch R, Brown AE, Smith CD, Webster HK. 1991. Rosette formation by Plasmodium coatneyi-infected red blood cells. Am. J. Trop. Med. Hyg. 44:399-401.
16. Nakano Y, Fujioka H, Luc KD, Rabbege JR, Todd GD, Collins WE, Aikawa M. 1996. A correlation of the sequestration rate of Plasmodium coatneyi-infected erythrocytes in cerebral and subcutaneous tissues of a rhesus monkey. Am. J. Trop. Med. Hyg. 55:311-314.
17. Davison BB, Cogswell FB, Baskin GB, Falkenstein KP, Henson EW, Tarantal AF, Krogstad DJ. 1998. Plasmodium coatneyi in the rhesus monkey (Macaca mulatta) as a model of malaria in pregnancy. Am. J. Trop. Med. Hyg. 59:189-201.
18. Davison BB, Cogswell FB, Baskin GB, Falkenstein KP, Henson EW, Krogstad DJ. 2000. Placental changes associated with fetal outcome in the Plasmodium coatneyi/rhesus monkey model of malaria in pregnancy. Am. J. Trop. Med. Hyg. 63:158-173.
19. Yang C, Xiao L, Tongren JE, Sullivan J, Lal AA, Collins WE. 1999. Cytokine production in rhesus monkeys infected with Plasmodium coatneyi. Am. J. Trop. Med. Hyg. 61:226-229.
20. Coatney RG, Collins WE, Warren M, Contacos PG. 1971. The primate malarias. US Goverment Printing Office, Washington, DC.
21. Collins WE, Warren M, Sullivan JS, Galland GG. 2001. Plasmodium coatneyi: observations on periodicity, mosquito infection, and transmission to Macaca mulatta monkeys. Am. J. Trop. Med. Hyg. 64:101-110.
22. Grizzard MB, London WT, Sly DL, Murphy BR, James WD, Parnell WP, Chanock RM. 1978. Experimental production of respiratory tract disease in cebus monkeys after intratracheal or intranasal infection with influenza A/Victoria/3/75 or influenza A/New Jersey/76 virus. Infect. Immun. 21:201-205.
23. Pasquale D, Chikkappa G. 1986. Comparative evaluation of bone marrow aspirate particle smears, biopsy imprints, and biopsy sections. Am. J. Hematol. 22:381-389.
24. Eyles DE, Fong YL, Warren M, Guinn E, Sandosham AA, Wharton RH. 1962. Plasmodium coatneyi, a new species of primate malaria from Malaya. Am. J. Trop. Med. Hyg. 11:597-604.
25. Moreno A, Garcia A, Cabrera-Mora M, Strobert E, Galinski MR. 2007. Disseminated intravascular coagulation complicated by peripheral gangrene in a rhesus macaque (Macaca mulatta) experimentally infected with Plasmodium coatneyi. Am. J. Trop. Med. Hyg. 76:648-654.
26. Galinski MR, Corredor V. 2004. Variant antigen expression in malaria infections: posttranscriptional gene silencing, virulence and severe pathology. Mol. Biochem. Parasitol. 134:17-25.
27. Scherf A, Lopez-Rubio JJ, Riviere L. 2008. Antigenic variation in Plasmodium falciparum. Annu. Rev. Microbiol. 62:445-470.
28. Evans KJ, Hansen DS, van Rooijen N, Buckingham LA, Schofield L. 2006. Severe malarial anemia of low parasite burden in rodent models results from accelerated clearance of uninfected erythrocytes. Blood 107: 1192-1199.
29. Valeri CR, MacGregor H, Giorgio A, Srey R, Ragno G. 2003. Comparison of radioisotope methods and a nonradioisotope method to measure the RBC volume and RBC survival in the baboon. Transfusion 43: 1366-1373.
30. Kurata M, Suzuki M, Agar NS. 1993. Antioxidant systems and erythrocyte life-span in mammals. Comp. Biochem. Physiol. B 106:477-487.
31. Marsh K, Kinyanjui S. 2006. Immune effector mechanisms in malaria. Parasite Immunol. 28:51-60.
32. Nguyen PH, Day N, Pram TD, Ferguson DJ, White NJ. 1995. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans. R. Soc. Trop. Med. Hyg. 89:200-204.
33. Kremsner PG, Valim C, Missinou MA, Olola C, Krishna S, Issifou S, Kombila M, Bwanaisa L, Mithwani S, Newton CR, Agbenyega T, Pinder M, Bojang K, Wypij D, Taylor T. 2009. Prognostic value of circulating pigmented cells in African children with malaria. J. Infect. Dis. 199:142-150.
34. Ponsford MJ, Medana IM, Prapansilp P, Hien TT, Lee SJ, Dondorp AM, Esiri MM, Day NP, White NJ, Turner GD. 2012. Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J. Infect. Dis. 205:663-671.
35. Castillo P, Menendez C, Mayor A, Carrilho C, Ismail MR, Lorenzoni C, Machungo F, Osman N, Quinto L, Romagosa C, Dobano C, Alonso PL, Ordi J, Bottieau E. 2012. Massive Plasmodium falciparum visceral sequestration: a cause of maternal death in Africa. Clin. Microbiol. Infect. doi:10.1111/1469-0691.12068.
36. Beeson JG, Duffy PE. 2005. The immunology and pathogenesis of malaria during pregnancy. Curr. Top. Microbiol. Immunol. 297:187-227.
37. Duffy PE. 2007. Plasmodium in the placenta: parasites, parity, protection, prevention and possibly preeclampsia. Parasitology 134:1877-1881.
38. Maitland K, Marsh K. 2004. Pathophysiology of severe malaria in children. Acta Trop. 90:131-140.
39. Cunnington AJ, Riley EM, Walther M. 2013. Microvascular dysfunc-tion in severe Plasmodium falciparum malaria. J. Infect. Dis. 207:369-370.
40. Price RN, Douglas NM, Anstey NM. 2009. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr. Opin. Infect. Dis. 22:430-435.
41. Anstey NM, Russell B, Yeo TW, Price RN. 2009. The pathophysiology of vivax malaria. Trends Parasitol. 25:220-227.
42. William T, Menon J, Rajahram G, Chan L, Ma G, Donaldson S, Khoo S, Frederick C, Jelip J, Anstey NM, Yeo TW. 2011. Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia. Emerg. Infect. Dis. 17:1248-1255.
43. Rest JR. 1982. Cerebral malaria in inbred mice. I. A new model and its pathology. Trans. R. Soc. Trop. Med. Hyg. 76:410-415.
44. Finley RW, Mackey LJ, Lambert PH. 1982. Virulent P. berghei malaria: prolonged survival and decreased cerebral pathology in cell-dependent nude mice. J. Immunol. 129:2213-2218.
45. Kawai S, Aikawa M, Kano S, Suzuki M. 1993. A primate model for severe human malaria with cerebral involvement: Plasmodium coatneyiinfected Macaca fuscata. Am. J. Trop. Med. Hyg. 48:630-636.
46. Sein KK, Brown AE, Maeno Y, Smith CD, Corcoran KD, Hansukjariya P, Webster HK, Aikawa M. 1993. Sequestration pattern of parasitized erythrocytes in cerebrum, mid-brain, and cerebellum of Plasmodium coatneyi-infected rhesus monkeys (Macaca mulatta). Am. J. Trop. Med. Hyg. 49:513-519.
47. Fujioka H, Millet P, Maeno Y, Nakazawa S, Ito Y, Howard RJ, Collins WE, Aikawa M. 1994. A nonhuman primate model for human cerebral malaria: rhesus monkeys experimentally infected with Plasmodium fragile. Exp. Parasitol. 78:371-376.
48. von Seidlein L, Olaosebikan R, Hendriksen IC, Lee SJ, Adedoyin OT, Agbenyega T, Nguah SB, Bojang K, Deen JL, Evans J, Fanello CI, Gomes E, Pedro AJ, Kahabuka C, Karema C, Kivaya E, Maitland K, Mokuolu OA, Mtove G, Mwanga-Amumpaire J, Nadjm B, Nansumba M, Ngum WP, Onyamboko MA, Reyburn H, Sakulthaew T, Silamut K, Tshefu AK, Umulisa N, Gesase S, Day NP, White NJ, Dondorp AM. 2012. Predicting the clinical outcome of severe falciparum malaria in African children: findings from a large randomized trial. Clin. Infect. Dis. 54:1080-1090.
49. Dondorp AM, Lee SJ, Faiz MA, Mishra S, Price R, Tjitra E, Than M, Htut Y, Mohanty S, Yunus EB, Rahman R, Nosten F, Anstey NM, Day NPJ, White NJ. 2008. The relationship between age and the manifestations of and mortality associated with severe malaria. Clin. Infect. Dis. 47:151-157.
50. Chang KH, Tam M, Stevenson MM. 2004. Inappropriately low reticulocytosis in severe malarial anemia correlates with suppression in the development of late erythroid precursors. Blood 103:3727-3735.
51. Chang KH, Tam M, Stevenson MM. 2004. Modulation of the course and outcome of blood-stage malaria by erythropoietin-induced reticulocytosis. J. Infect. Dis. 189:735-743.
52. Helegbe G, Huy N, Yanagi T, Shuaibu M, Yamazaki A, Kikuchi M, Yasunami M, Hirayama K. 2009. Rate of red blood cell destruction varies in different strains of mice infected with Plasmodium berghei-ANKA after chronic exposure. Malaria J. 8:91. doi:10.1186/1475-2875-8-91.
53. Abdalla S, Wickramasinghe S. 2004. The bone marrow in human malaria, p 213-248. In Abdalla S, Pasvol G (ed), Malaria. A hematological perspective. Imperial College Press, London, United Kingdom.
54. Dörmer P, Dietrich M, Kern P, Horstmann RD. 1983. Ineffective erythropoiesis in acute human P. falciparum malaria. Ann. Hematol. 46:279-288.
55. Were T, Hittner J, Ouma C, Otieno R, Orago A, Ong'echa J, Vulule J, Keller C, Perkins D. 2006. Suppression of RANTES in children with Plasmodium falciparum malaria. Haematologica 91:1396-1399.
56. Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirjaroen L, ter Kuile F, Chongsuphajaisiddhi T, White NJ. 2001. Factors contributing to anemia after uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 65:614-622.
57. Looareesuwan S, Merry AH, Phillips RE, Pleehachinda R, Wattanagoon Y, Ho M, Charoenlarp P, Warrell DA, Weatherall DJ. 1987. Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients. Br. J. Haematol. 67:473-478.
58. Looareesuwan S, Davis TME, Pukrittayakamee S, Supanaranond W, Desakorn V, Silamut K, Krishna S, Boonamrung S, White NJ. 1991. Erythrocyte survival in severe falciparum malaria. Acta Trop. 48:263-270.
59. Naumann KM, Jones GL, Saul A, Smith R. 1992. Parasite-induced changes to localized erythrocyte membrane deformability in Plasmodium falciparum cultures. Immunol. Cell Biol. 70(Part 4):267-275.
60. Dondorp AM, Angus BJ, Chotivanich K, Silamut K, Ruangveerayuth R, Hardeman MR, Kager PA, Vreeken J, White NJ. 1999. Red blood cell deformability as a predictor of anemia in severe falciparum malaria. Am. J. Trop. Med. Hyg. 60:733-737.
61. Kiefer CR, Snyder LM. 2000. Oxidation and erythrocyte senescence. Curr. Opin. Hematol. 7:113-116.
62. Waitumbi JN, Donvito B, Kisserli A, Cohen JH, Stoute JA. 2004. Age-related changes in red blood cell complement regulatory proteins and susceptibility to severe malaria. J. Infect. Dis. 190:1183-1191.
63. Waitumbi JN, Opollo MO, Muga RO, Misore AO, Stoute JA. 2000. Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia. Blood 95:1481-1486.
64. Odhiambo C, Otieno W, Adhiambo C, Odera M, Stoute J. 2008. Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia. BMC Med. 6:23. doi:10.1186/1741-7015-6-23.
65. Owuor BO, Odhiambo CO, Otieno WO, Adhiambo C, Makawiti DW, Stoute JA. 2008. Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia. Mol. Med. 14:89-97.
66. Pawluczkowycz AW, Lindorfer MA, Waitumbi JN, Taylor RP. 2007. Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria. J. Immunol. 179:5543-5552.
67. Greve B, Lehman LG, Lell B, Luckner D, Schmidt-Ott R, Kremsner PG. 1999. High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria. J. Infect. Dis. 179:1584-1586.
68. Ogonda LA, Orago ASS, Otieno MF, Adhiambo C, Otieno W, Stoute JA. 2010. The levels of CD16/Fcγ receptor IIIA on CD14+ CD16+ monocytes are higher in children with severe Plasmodium falciparum anemia than in children with cerebral or uncomplicated malaria. Infect. Immun. 78:2173-2181.
69. Gasque P. 2004. Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 41:1089-1098.
70. Facer CA, Bray RS, Brown J. 1979. Direct Coombs antiglobulin reactions in Gambian children with Plasmodium falciparum malaria. I. Incidence and class specificity. Clin. Exp. Immunol. 35:119-127.
71. Omodeo-Sale F, Motti A, Basilico N, Parapini S, Olliaro P, Taramelli D. 2003. Accelerated senescence of human erythrocytes cultured with Plasmodium falciparum. Blood 102:705-711.
72. Gupta CM, Alam A, Mathur PN, Dutta GP. 1982. A new look at nonparasitized red cells of malaria-infected monkeys. Nature 299:259-261.
73. Burchard GD, Radloff P, Philipps J, Nkeyi M, Knobloch J, Kremsner PG. 1995. Increased erythropoietin production in children with severe malarial anemia. Am. J. Trop. Med. Hyg. 53:547-551.
74. Burgmann H, Looareesuwan S, Kapiotis S, Viravan C, Vanijanonta S, Hollenstein U, Wiesinger E, Presterl E, Winkler S, Graninger W. 1996. Serum levels of erythropoietin in acute Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 54:280-283.
75. El Hassan AM, Saeed AM, Fandrey J, Jelkmann W. 1997. Decreased erythropoietin response in Plasmodium falciparum malaria-associated anaemia. Eur. J. Haematol. 59:299-304.
76. Diez-Padrisa N, Aguilar R, Machevo S, Morais L, Nhampossa T, O'Callaghan-Gordo C, Nhalungo D, Menendez C, Roca A, Alonso PL, Bassat Q. 2011. Erythropoietin levels are not independently associated with malaria-attributable severe disease in Mozambican children. PLoS One 6:e24090. doi:10.1371/journal.pone.0024090.
77. D'Ombrain MC, Robinson LJ, Stanisic DI, Taraika J, Bernard N, Michon P, Mueller I, Schofield L. 2008. Association of early interferongamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children. Clin. Infect. Dis. 47:1380-1387.
78. Pombo DJ, Lawrence G, Hirunpetcharat C, Rzepczyk C, Bryden M, Cloonan N, Anderson K, Mahakunkijcharoen Y, Martin LB, Wilson D, Elliott S, Eisen DP, Weinberg JB, Saul A, Good MF. 2002. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 360:610-617.
79. McCall MB, Hopman J, Daou M, Maiga B, Dara V, Ploemen I, Nganou-Makamdop K, Niangaly A, Tolo Y, Arama C, Bousema JT, van der Meer JW, van der Ven AJ, Troye-Blomberg M, Dolo A, Doumbo OK, Sauerwein RW. 2010. Early interferon-gamma response against Plasmodium falciparum correlates with interethnic differences in susceptibility to parasitemia between sympatric Fulani and Dogon in Mali. J. Infect. Dis. 201:142-152.
80. Bostrom S, Giusti P, Arama C, Persson JO, Dara V, Traore B, Dolo A, Doumbo O, Troye-Blomberg M. 2012. Changes in the levels of cytokines, chemokines and malaria-specific antibodies in response to Plasmodium falciparum infection in children living in sympatry in Mali. Malar J. 11:109.
81. Selleri C, Maciejewski J, Sato T, Young N. 1996. Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 87: 4149-4157.
82. Roodman GD, Bird A, Hutzler D, Montgomery W. 1987. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp. Hematol. 15:928-935.
83. Dai C, Chung IJ, Jiang S, Price JO, Krantz SB. 2003. Reduction of cell cycle progression in human erythroid progenitor cells treated with tumour necrosis factor alpha occurs with reduced CDK6 and is partially reversed by CDK6 transduction. Br. J. Haematol. 121:919-927.
84. De Maria R, Zeuner A, Eramo A, Domenichelli C, Bonci D, Grignani F, Srinivasula SM, Alnemri ES, Testa U, Peschle C. 1999. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 401:489-493.
85. Clark IA, Chaudhri G. 1988. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br. J. Haematol. 70:99-103.
86. Poovassery JS, Sarr D, Smith G, Nagy T, Moore JM. 2009. Malariainduced murine pregnancy failure: distinct roles for IFN-gamma and TNF. J. Immunol. 183:5342-5349.
87. Awandare GA, Goka B, Boeuf P, Tetteh JK, Kurtzhals JA, Behr C, Akanmori BD. 2006. Increased levels of inflammatory mediators in children with severe Plasmodium falciparum malaria with respiratory distress. J. Infect. Dis. 194:1438-1446.
88. Day NP, Hien TT, Schollaardt T, Loc PP, Chuong LV, Chau TT, Mai NT, Phu NH, Sinh DX, White NJ, Ho M. 1999. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J. Infect. Dis. 180:1288-1297.
89. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, Kone A, Harley R, Plowe CV, Doumbo OK, Sztein MB. 2004. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1{beta}), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect. Immun. 72:5630-5637.
90. Urquhart AD. 1994. Putative pathophysiological interactions of cytokines and phagocytic cells in severe human falciparum malaria. Clin. Infect. Dis. 19:117-131.
91. Robinson LJ, D'Ombrain MC, Stanisic DI, Taraika J, Bernard N, Richards JS, Beeson JG, Tavul L, Michon P, Mueller I, Schofield L. 2009. Cellular tumor necrosis factor, gamma interferon, and interleukin- 6 responses as correlates of immunity and risk of clinical Plasmodium falciparum Malaria in children from Papua New Guinea. Infect. Immun. 77:3033-3043.
92. Gourley IS, Kurtis JD, Kamoun M, Amon JJ, Duffy PE. 2002. Profound bias in interferon-gamma and interleukin-6 allele frequencies in western Kenya, where severe malarial anemia is common in children. J. Infect. Dis. 186:1007-1012.
93. Ochiel DO, Awandare GA, Keller CC, Hittner JB, Kremsner PG, Weinberg JB, Perkins DJ. 2005. Differential regulation of betachemokines in children with Plasmodium falciparum malaria. Infect. Immun. 73:4190-4197.
94. Abrams ET, Brown H, Chensue SW, Turner GDH, Tadesse E, Lema VM, Molyneux ME, Rochford R, Meshnick SR, Rogerson SJ. 2003. Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated β chemokine expression. J. Immunol. 170:2759-2764.
95. Dong S, Kurtis JD, Pond-Tor S, Kabyemela E, Duffy PE, Fried M. 2012. CXC ligand 9 response to malaria during pregnancy is associated with low-birth-weight deliveries. Infect. Immun. 80:3034-3038.
96. John CC, Opika-Opoka R, Byarugaba J, Idro R, Boivin MJ. 2006. Low levels of RANTES are associated with mortality in children with cerebral malaria. J. Infect. Dis. 194:837-845.
97. Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC, Anderson W, Adjei AA, Gyasi RK, Tettey Y, Wiredu EK, Tongren JE, Udhayakumar V, Stiles JK. 2007. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malaria J. 6:147. doi:10 .1186/1475-2875-6-147.
98. Gleissner CA, von Hundelshausen P, Ley K. 2008. Platelet chemokines in vascular disease. Arterioscler. Thromb. Vasc. Biol. 28:1920-1927.
99. de Mast Q, de Groot PG, van Heerde WL, Roestenberg M, van Velzen JF, Verbruggen B, Roest M, McCall M, Nieman AE, Westendorp J, Syafruddin D, Fijnheer R, van Dongen-Lases EC, Sauerwein RW, van der Ven AJ. 2010. Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy. Br. J. Haematol. 151:495-503.
100. Supanaranond W, Davis TME, Dawes J, Silamut K, Vilaiwanna N, White NJ. 1992. In-vivo platelet activation and anomalous thrombospondin levels in severe falciparum malaria. Platelets 3:195-200.
101. Geurts N, Opdenakker G, Van den Steen PE. 2012. Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections. Pharmacol. Ther. 133:257-279.
102. Dietmann A, Helbok R, Lackner P, Issifou S, Lell B, Matsiegui PB, Reindl M, Schmutzhard E, Kremsner PG. 2008. Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity. J. Infect. Dis. 197:1614-1620.
103. Heissig B, Nishida C, Tashiro Y, Sato Y, Ishihara M, Ohki M, Gritli I, Rosenkvist J, Hattori K. 2010. Role of neutrophil-derived matrix metalloproteinase- 9 in tissue regeneration. Histol. Histopathol. 25:765-770.
104. Santos-Martinez MJ, Medina C, Jurasz P, Radomski MW. 2008. Role of metalloproteinases in platelet function. Thromb. Res. 121:535-542.
105. Prato M, Giribaldi G. 2011. Matrix metalloproteinase-9 and haemozoin: wedding rings for human host and Plasmodium falciparum parasite in complicated malaria. J. Trop. Med. 2011:628435. doi:10.1155/2011 /628435.
106. Brown HC, Chau TT, Mai NT, Day NP, Sinh DX, White NJ, Hien TT, Farrar J, Turner GD. 2000. Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology 55:104-111.
107. Shio MT, Kassa FA, Bellemare MJ, Olivier M. 2010. Innate inflammatory response to the malarial pigment hemozoin. Microbes Infect. 12: 889-899.
108. Schwarzer E, Turrini F, Ulliers D, Giribaldi G, Ginsburg H, Arese P. 1992. Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J. Exp. Med. 176:1033-1041.
109. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, Uematsu S, Yamamoto M, Takeuchi O, Itagaki S, Kumar N, Horii T, Akira S. 2005. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201:19-25.
110. Skorokhod OA, Alessio M, Mordmüller B, Arese P, Schwarzer E. 2004. Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferatoractivated receptor-γ-mediated effect. J. Immunol. 173:4066-4074.
111. Morakote N, Justus DE. 1988. Immunosuppression in malaria: effect of hemozoin produced by Plasmodium berghei and Plasmodium falciparum. Int. Arch. Allergy Appl. Immunol. 86:28-34.
112. Scorza T, Magez S, Brys L, De Baetselier P. 1999. Hemozoin is a key factor in the induction of malaria-associated immunosuppression. Parasite Immunol. 21:545-554.
113. Casals-Pascual C, Kai O, Cheung JO, Williams S, Lowe B, Nyanoti M, Williams TN, Maitland K, Molyneux M, Newton CR, Peshu N, Watt SM, Roberts DJ. 2006. Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood 108:2569-2577.
114. Awandare GA, Kempaiah P, Ochiel DO, Piazza P, Keller CC, Perkins DJ. 2011. Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model. Am. J. Hematol. 86:155-162.
115. Giribaldi G, Ulliers D, Schwarzer E, Roberts I, Piacibello W, Arese P. 2004. Hemozoin- and 4-hydroxynonenal-mediated inhibition of eryth-ropoiesis. Possible role in malarial dyserythropoiesis and anemia. Haematologica 89:492-493.
116. Lamikanra AA, Theron M, Kooij TW, Roberts DJ. 2009. Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors. PLoS One 4:e8446. doi:10.1371/journal.pone.0008446.
117. Skorokhod OA, Caione L, Marrocco T, Migliardi G, Barrera V, Arese P, Piacibello W, Schwarzer E. 2010. Inhibition of erythropoiesis in malaria anemia: role of hemozoin and hemozoin-generated 4-hydroxynonenal. Blood 116:4328-4337.
118. Metzger WG, Mordmüller BG, Kremsner PG. 1995. Malaria pigment in leucocytes. Trans. R. Soc. Trop. Med. Hyg. 89:637-638.
119. Amodu OK, Adeyemo AA, Olumese PE, Gbadegesin RA. 1998. Intraleucocytic malaria pigment and clinical severity of malaria in children. Trans. R. Soc. Trop. Med. Hyg. 92:54-56.
120. Nilsson-Ehle I, Nilsson-Ehle P. 1990. Changes in plasma lipoproteins in acute malaria. J. Intern. Med. 227:151-155.
121. Faucher JF, Ngou-Milama E, Missinou MA, Ngomo R, Kombila M, Kremsner PG. 2002. The impact of malaria on common lipid parameters. Parasitol. Res. 88:1040-1043.
122. Parola P, Gazin P, Patella F, Badiaga S, Delmont J, Brouqui P. 2004. Hypertriglyceridemia as an indicator of the severity of falciparum malaria in returned travelers: a clinical retrospective study. Parasitol. Res. 92:464-466.
123. Das BS, Patnaik JK, Mohanty S, Mishra SK, Mohanty D, Satpathy SK, Bose TK. 1993. Plasma antioxidants and lipid peroxidation products in falciparum malaria. Am. J. Trop. Med. Hyg. 49:720-725.
124. Al Rifai W, Maurois P, Fruchart JC, Charet P. 1982. Adipose tissue lipoprotein lipase activity in Plasmodium chabaudi and Plasmodium vinckei rodent malaria. Biochimie 64:127-132.
125. Morin CL, Schlaepfer IR, Eckel RH. 1995. Tumor necrosis factor-alpha eliminates binding of NF-Y and an octamer-binding protein to the lipoprotein lipase promoter in 3T3-L1 adipocytes. J. Clin. Invest. 95:1684-1689.
126. Chotivanich K, Mungthin M, Ruengweerayuth R, Udomsangpetch R, Dondorp A, Singhasivanon P, Pukrittayakamee S, White N. 2012. The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum. Malaria J. 11:177. doi:10.1186 /1475-2875-11-177.
127. Davis TME, Suputtamongkol Y, Spencer JL, Ford S, Chienkul N, Schulenburg WE, White NJ. 1992. Measures of capillary permeability in acute falciparum malaria: relation to severity of infection and treatment. Clin. Infect. Dis. 15:256-266.
128. Areekul S. 1986. Plasmodium coatneyi: alterations of transcapillary escape rate and capillary permeability to fibrinogen in rhesus monkeys. Exp. Parasitol. 61:304-310.
129. Graninger W, Thalhammer F, Hollenstein U, Zotter GM, Kremsner PG. 1992. Serum protein concentrations in Plasmodium falciparum malaria. Acta Trop. 52:121-128.
130. Charoenpan P, Indraprasit S, Kiatboonsri S, Suvachittanont O, Tanomsup S. 1990. Pulmonary edema in severe falciparum malaria. Hemodynamic study and clinicophysiologic correlation. Chest 97:1190-1197.
131. Tachibana S, Sullivan SA, Kawai S, Nakamura S, Kim HR, Goto N, Arisue N, Palacpac NM, Honma H, Yagi M, Tougan T, Katakai Y, Kaneko O, Mita T, Kita K, Yasutomi Y, Sutton PL, Shakhbatyan R, Horii T, Yasunaga T, Barnwell JW, Escalante AA, Carlton JM, Tanabe K. 2012. Plasmodium cynomolgi genome sequences provide insight into Plasmodium vivax and the monkey malaria clade. Nat. Genet. 44:1051-1055.